Zhu J, Hu Z, Luo Y, Liu Y, Luo W, Du X et al. Diabetic peripheral neuropathy: pathogenetic mechanisms and treatment. Front Endocrinol (Lausanne) [Internet]. 2023; 14:1265372. Available from: https://doi.org/10.3389/fendo.2023.1265372
Akter N. Diabetic peripheral neuropathy: epidemiology, physiopathology, diagnosis and treatment. Delta Med Coll J [Internet]. 2019;7(1):35–48. https://doi.org/10.3329/dmcj.v7i1.40619.
Laddad M, Bahulekar A, Ghorpade VV. Peripheral neuropathy: A review of epidemiology, pathophysiology, and management options. OGF [Internet]. 2024 [cited 2024 Nov 24];34(3s):635–44. Available from: https://www.obstetricsandgynaecologyforum.com/index.php/ogf/article/view/326
Mallick-Searle T, Adler JA. Update on treating painful diabetic peripheral neuropathy: a review of current US guidelines with a focus on the most recently approved management options. J Pain Res. 2024;17:1005–28. https://doi.org/10.2147/JPR.S442595.
Article PubMed PubMed Central Google Scholar
Gandhi M, Fargo E, Prasad-Reddy L, Mahoney KM, Isaacs D. Diabetes: how to manage diabetic peripheral neuropathy. Drugs in Context. 2022. https://doi.org/10.7573/dic.2021-10-2.
Article PubMed PubMed Central Google Scholar
Atmaca A, Ketenci A, Sahin I, Sengun IS, Oner RI, Erdem Tilki H, et al. Expert opinion on screening, diagnosis, and management of diabetic peripheral neuropathy: a multidisciplinary approach. Front Endocrinol (Lausanne). 2024;15:1380929. https://doi.org/10.3389/fendo.2024.1380929.
Ray J, Sahoo CK, Mohanty R, Sahoo R, Dalai R. A review on diabetic peripheral neuropathy. J Drug Deliv Ther. 2021;11(2-S):121–5. https://doi.org/10.22270/jddt.v11i2-s.4642.
Geeso J, Galan C. Diabetic Neuropathic Pain: Pathophysiology & Treatment [Internet]. Preprints. 2023. Available from: https://doi.org/10.20944/preprints202305.1240.v1
Yorek M. Combination therapy is it in the future for successfully treating peripheral diabetic neuropathy? Front Endocrinol (Lausanne). 2024;15:1357859. https://doi.org/10.3389/fendo.2024.1357859.
Niimi N, Yako H, Takaku S, Chung SK. Aldose reductase and the polyol pathway in Schwann cells: old and new problems. Int J Mol Sci. 2021;22(3):1031. https://doi.org/10.3390/ijms22031031.
Article PubMed PubMed Central CAS Google Scholar
M SL, O P. Inflammatory biomarkers as a part of diagnosis in diabetic peripheral neuropathy. J Diabetes Metab Disord. 2021;20(1):869–82. https://doi.org/10.1007/s40200-021-00734-1.
Article PubMed PubMed Central Google Scholar
Akram R, Anwar H, Javed MS, Imran A, Rasul A, Malik SA, et al. Natural molecules as promising players against diabetic peripheral neuropathy: an emerging nutraceutical approach. Int J Food Prop. 2023;26(1):894–914. https://doi.org/10.1080/10942912.2023.2189569.
Pathak R, Sachan N, Chandra P. Mechanistic approach towards diabetic neuropathy screening techniques and future challenges: A review. Biomed Pharmacother [Internet]. 2022;150(113025):113025. Available from: https://doi.org/10.1016/j.biopha.2022.113025
Mizukami H, Osonoi S. Pathogenesis and molecular treatment strategies of diabetic neuropathy collateral glucose-utilizing pathways in diabetic polyneuropathy. Int J Mol Sci [Internet]. 2020;22(1):94. Available from: https://doi.org/10.3390/ijms22010094
Lv Y, Yao X, Li X, Ouyang Y, Fan C, Qian Y. Cell metabolism pathways involved in the pathophysiological changes of diabetic peripheral neuropathy. Neural Regen Res. 2024;19(3):598–605. https://doi.org/10.4103/1673-5374.380872.
Article PubMed CAS Google Scholar
Ab Hamid, N., Omar, N., Ismail, C. A. N., & Long, I. (2021). Insight of Mechanism and Signaling Pathway in Pathogenesis of Diabetic Neuropathy: A Review: Pathogenesis of Diabetic Neuropathy. IIUM Medical Journal Malaysia, 20(4).
Saleh, D. O., & Sedik, A. A. (2024). Novel drugs affecting diabetic peripheral neuropathy. Iranian Journal of Basic Medical Sciences, 27(6), 657.
Jubaidi FF, Zainalabidin S, Taib IS, Abdul Hamid Z, Mohamad Anuar NN, Jalil J, et al. The role of PKC-MAPK signaling pathways in the development of hyperglycemia-induced cardiovascular complications. Int J Mol Sci. 2022;23(15):8582. https://doi.org/10.3390/ijms23158582.
Article PubMed PubMed Central CAS Google Scholar
Tang H-Y, Jiang A-J, Ma J-L, Wang F-J, Shen G-M. Understanding the signaling pathways related to the mechanism and treatment of diabetic peripheral neuropathy. Endocrinology. 2019;160(9):2119–27. https://doi.org/10.1210/en.2019-00311.
Article PubMed CAS Google Scholar
Feldman EL, Nave K-A, Jensen TS, Bennett DLH. New Horizons in diabetic neuropathy: Mechanisms, bioenergetics, and pain. Neuron. 2017;93(6):1296–313. https://doi.org/10.1016/j.neuron.2017.02.005.
Article PubMed PubMed Central CAS Google Scholar
Pan D, Xu L, Guo M. The role of protein kinase C in diabetic microvascular complications. Front Endocrinol (Lausanne). 2022;13:973058. https://doi.org/10.3389/fendo.2022.973058.
Ratan Y, Rajput A, Pareek A, Pareek A, Kaur R, Sonia S, et al. Recent advances in biomolecular patho-mechanistic pathways behind the development and progression of diabetic neuropathy. Biomedicines. 2024;12(7):1390. https://doi.org/10.3390/biomedicines12071390.
Article PubMed PubMed Central CAS Google Scholar
Pang L, Lian X, Liu H, Zhang Y, Li Q, Cai Y, et al. Understanding diabetic neuropathy: focus on oxidative stress. Oxid Med Cell Longev. 2020;2020:9524635. https://doi.org/10.1155/2020/9524635.
Article PubMed PubMed Central CAS Google Scholar
Weng L, Zhang F, Wang R, Ma W, Song Y. A review on protective role of genistein against oxidative stress in diabetes and related complications. Chem Biol Interact. 2019;310:108665. https://doi.org/10.1016/j.cbi.2019.05.031.
Article PubMed CAS Google Scholar
Singh A, Kukreti R, Saso L, Kukreti S. Mechanistic insight into oxidative stress-triggered signaling pathways and type 2 diabetes. Molecules. 2022;27(3):950. https://doi.org/10.3390/molecules27030950.
Article PubMed PubMed Central CAS Google Scholar
Redza-Dutordoir M, Averill-Bates DA. Interactions between reactive oxygen species and autophagy: Special issue: Death mechanisms in cellular homeostasis. Biochim Biophys Acta Mol Cell Res [Internet]. 2021;1868(8):119041. Available from: https://doi.org/10.1016/j.bbamcr.2021.119041
Mahmood DF, Ahmad DS. Pathophysiology and pharmacotherapeutics of diabetic neuropathy: a review. Sch J Appl Med Sci. 2022;10(12):2096–102. https://doi.org/10.36347/sjams.2022.v10i12.009.
Bellier J, Nokin M-J, Lardé E, Karoyan P, Peulen O, Castronovo V, et al. Methylglyoxal, a potent inducer of AGEs, connects between diabetes and cancer. Diabetes Res Clin Pract. 2019;148:200–11. https://doi.org/10.1016/j.diabres.2019.01.002.
Article PubMed CAS Google Scholar
Wu T-H, Tsai S-C, Lin H-W, Chen C-N, Hwu C-M. Increased serum levels of advanced glycation end products are negatively associated with relative muscle strength in patients with type 2 diabetes mellitus. BMC Endocr Disord. 2022;22(1):118. https://doi.org/10.1186/s12902-022-01035-1.
Article PubMed PubMed Central CAS Google Scholar
Zhao X-W, Yue W-X, Zhang S-W, Chen Q. Correlation between the accumulation of skin glycosylation end products and the development of type 2 diabetic peripheral neuropathy. BMC Endocr Disord. 2022;22(1):106. https://doi.org/10.1186/s12902-022-00997-6.
Article PubMed PubMed Central CAS Google Scholar
Al-Saoudi E, Christensen MMB, Nawroth P, Fleming T, Hommel EE, Jørgensen ME, et al. Advanced glycation end-products are associated with diabetic neuropathy in young adults with type 1 diabetes. Front Endocrinol (Lausanne). 2022;13:891442. https://doi.org/10.3389/fendo.2022.891442.
Yang K, Wang Y, Li Y-W, Chen Y-G, Xing N, Lin H-B, et al. Progress in the treatment of diabetic peripheral neuropathy. Biomed Pharmacother. 2022;148:112717. https://doi.org/10.1016/j.biopha.2022.112717.
Article PubMed CAS Google Scholar
Khdour MR. Treatment of diabetic peripheral neuropathy: a review. J Pharm Pharmacol. 2020;72(7):863–72. https://doi.org/10.1111/jphp.13241.
Article PubMed CAS Google Scholar
Pop-Busui R, Ang L, Boulton A, Feldman E, Marcus R, Mizokami-Stout K, et al. Diagnosis and treatment of painful diabetic peripheral neuropathy. ADA Clinical Compendia. 2022;2022(1):1–32. https://doi.org/10.2337/db2022-01.
Onakpoya, I. J., Thomas, E. T., Lee, J. J., Goldacre, B., & Heneghan, C. J. (2019). Benefits and harms of pregabalin in the management of neuropathic pain: a
Comments (0)